CLOs on the Move

West Edmonton Dental Care

www.drherchen.com

 
West Edmonton Dental Care is a Courtland, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Management Resource Solutions

Management Resource Solutions is a Thousand Oaks, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Ideomed

Ideomed is a Grand Rapids, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Grant Regional Health Center

Grant Regional Health Center is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Grant Regional Health Center is based in Lancaster, WI. You can find more information on Grant Regional Health Center at www.grantregional.com

Ideal Image

IDEAL IMAGE is a premier global leader in laser hair removal and non-surgical medical cosmetic services. With over 120 locations, our success is attributed to a shared passion for "Changing people`s lives forever!" We use only licensed medical and nursing professionals to perform our treatments. If you are interested in joining a company that values its employees and encourages job ownership in a supportive environment, please visit our career site at www.idealimage.com to learn more about the company and view a list of open positions.

Furiex

Furiex Pharmaceuticals, Inc., a drug development company, engages in the compound partnering business primarily in the United States. It collaborates with pharmaceutical and biotechnology companies to enhance the value of their drug candidates by applying its novel approach to drug development. The company’s products under development include Eluxadoline1, a mu opioid receptor agonist and delta opioid receptor antagonist, which is in Phase III clinical trials for the treatment of diarrhea-predominant irritable bowel syndrome; and Avarofloxacin1, a Phase III-ready fluoroquinolone antibiotic for the treatment of acute bacterial skin and skin structure infections. It is also developing SYR-472, which is in Phase III clinical trials for the treatment of Type-2 diabetes. In addition, the company has rights to compounds in various stages of development and commercialization, which includes Nesina, Liovel, Oseni, and Kazano for the treatment of Type-2 diabetes, as well as Priligy for the treatment of premature ejaculation. The company was founded in 1998 and is headquartered in Morrisville, North Carolina.